Authors:
Nicoletti, MI
Valoti, G
Giannakakou, P
Zhan, ZR
Kim, JH
Lucchini, V
Landoni, F
Mayo, JG
Giavazzi, R
Fojo, T
Citation: Mi. Nicoletti et al., Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-anticancer drug screen: Correlation with sensitivity to microtubule active agents, CLIN CANC R, 7(9), 2001, pp. 2912-2922
Authors:
Kitazono, M
Robey, R
Zhan, ZR
Sarlis, NJ
Skarulis, MC
Aikou, T
Bates, S
Fojo, T
Citation: M. Kitazono et al., Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na+/I- symporter and iodine accumulationin poorly differentiated thyroid carcinoma cells, J CLIN END, 86(7), 2001, pp. 3430-3435
Authors:
Giannakakou, P
Poy, G
Zhan, ZR
Knutsen, T
Blagosklonny, MV
Fojo, T
Citation: P. Giannakakou et al., Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer, ONCOGENE, 19(27), 2000, pp. 3078-3085
Citation: Y. Chuman et al., Construction of gene therapy vectors targeting adrenocortical cells: Enhancement of activity and specificity with agents modulating the cyclic adenosine 3 ',5 '-monophosphate pathway, J CLIN END, 85(1), 2000, pp. 253-262
Authors:
Miyake, K
Mickley, L
Litman, T
Zhan, ZR
Robey, R
Cristensen, B
Brangi, M
Greenberger, L
Dean, M
Fojo, T
Bates, SE
Citation: K. Miyake et al., Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes, CANCER RES, 59(1), 1999, pp. 8-13